Asthma is a heterogeneous disease developed against various stimuli (indoor and outdoor allergens, cigarette, air pollution, etc.), associated with airway hypersensitivity and characterized by chronic airway inflammation. COVID-19 is a disease caused by a coronavirus strain called Severe Acute ...
Also, with the absence of data that would indicate any potential harm, current advice is to continue the administration of biological therapies during the COVID-19 pandemic in patients with asthma for whom such therapies are clearly indicated and have been effective. For patients with severe ...
Asthma is a common chronic lung disease, and COVID-19 pandemic as a respiratory viral disease led to lung infection and resulted in millions of deaths. So,... X Li,D Sheng,K Chen,... - 《Allergologia & Immunopathologia》 被引量: 0发表: 2024年 Asthma May Not be a Potential Risk Fa...
COVID-19 in asthma Asthma is a chronic heterogeneous disease defined by a history of respiratory symptoms that include wheezing, shortness of breath, chest tightness, and cough. An important feature of asthma is the variable intensity of expiratory airway limitation over time. Moreover, asthma bec...
If you don’t have a peak flow meter, think about getting one from your GP or pharmacist, as it can be a good way of tracking your asthma and helping to tell the difference between asthma symptoms and COVID-19 symptoms. It can also help your medical team to assess you over the ...
Asthma COVID-19 Corticosteroids Vaccine Abbreviations used ACE2 angiotensin-converting enzyme-2 COVID-19 coronavirus disease 2019 SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 Sorry, something went wrong. Please try again and make sure cookies are enabledReferences...
Objective To explore the influence of asthma and chronic obstructive pulmonary disease (COPD) comorbidity on disease expression and outcomes, and the potential underlying mechanisms in COVID patients. Methods A total of 961 hospitalized COVID patients with a definite clinical outcome (death or ...
Asthma is a common respiratory disease characterized by airway chronic inflammation, mucus overproduction, hyperresponsiveness, and remodelling. Normally, the majority of the disease is predominantly mediated by type 2 immune responses. The type 2 immune response involves T helper (Th) 2 cells, type ...
Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19Urszula Radzikowska, Andrzej Eljaszewicz, Ge Tan, Nino Stocker, Anja Heider, Patrick Westermann, Silvio Steiner, Anita Dreher, Paulina Wawrzyniak, Beate Rückert,...
Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings.